Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
MDxHealth SA
MDXH | US
3.27
USD-0.04
-1.21%
MDXH | US
About MDxHealth SA
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
30/06/2024
As of date
06/03/2026
Close
3.27
Open
3.30
High
3.38
Low
3.25
MDxHealth SA a commercial-stage precision diagnostics company provides urologic solutions in the United States Europe and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx a non-invasive urine test; and ConfirmMDx an epigenetic test which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal Belgium.
View LessMDXH | US
Risk
40.4
Sharpe
1.78
Luna's Score
51/100
Recommendation
Hold
Luna says (MDXH | US)
What's Working
Low Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Weak Operating Margin (< 10%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
27.4%1 month
40.4%3 months
54.5%6 months
62.3%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
3.55
Debt to equity
-6.43
Debt to assets
0.43
Ent. to EBITDA
-2.73
Ent. to rev.
1.61
PEG
-
Other Fundamentals
EBITDA
-18.62M
MarketCap
154.63M
MarketCap(USD)
154.63M
Div. yield
-
Op. margin
-32.38
Erngs. growth
-
Rev. growth
32.30
Ret. on equity
-457.29
Short ratio
0.34
Short perc.
0.11
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.53
Range1M
0.55
Range3M
1.34
Volumes: Market Activity
Rel. volume
1.08
Price X volume
417.33K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.73 | - | Cheaper |
| Ent. to Revenue | 1.61 | - | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 3.55 | 77.50 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 54.55 | - | Par |
| Debt to Equity | -6.43 | -14.36 | Expensive |
| Debt to Assets | 0.43 | 0.34 | Expensive |
| Market Cap | 154.63M | - | Emerging |
